Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Pell Bio-Med Technology Co., Ltd.
No Price
Closing Price XTAI 30.04.2026:
771,00 TWD
30.04.2026 05:30
Current Prices from Pell Bio-Med Technology Co., Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
TWSE
6949.TW
TWD
30.04.2026 05:30
771,00 TWD
-
Share Float & Liquidity
Free Float48,99 %
Shares Float31,78 M
Shares Outstanding64,87 M
Company Profile for Pell Bio-Med Technology Co., Ltd. Share
Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications. Its commercial products include good tissue practice laboratory infrastructure, adipose-derived stem cells (ADSC) for regenerative medicine, and CIK and DC-CIK against cancers. The company also develops medicines for various types of cancers, cell immunotherapy, and stem cell regenerative therapy technologies. In addition, it engages in the research and development of chimeric antigen receptor T cell (CAR-T), CAR-NK and CAR-?dT, and gene-modified ADSC. Further, the company develops products for B-NHL, ovarian cancer, multiple myeloma, and thyroid cancer indications. The company was founded in 2017 and is based in Taipei, Taiwan.
